How many insider declarations has Michael Engsig filed?

Michael Engsig has filed 5 public insider declarations with Oslo Børs.

What is Michael Engsig's role?

Michael Engsig's reported role is not specified by the regulator across the filings.

Which companies does Michael Engsig report trades for?

Michael Engsig reports trades for Nykode Therapeutics ASA.

← Executives ★ Sign in to follow

ME

Michael Engsig

NO·Oslo Børs

Nykode Therapeutics ASA

Cumul. flow

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Browse the full record of transactions filed by Michael Engsig. Insider active across 1 company, notably Nykode Therapeutics ASA. Aggregated, 5 reports have been published. Activity tracked since 31 October 2023. The latest transaction was disclosed on 24 November 2025 (Purchase). Regulator: Oslo Børs. The full history is openly available.

Declarations5 total

●

Michael Engsig

Executives24 Nov 2025(filed)Nykode Therapeutics ASA

NOK 100,1294Oslo ↗

46,356 shares@ NOK 2.1621.2% of flowShareXOSLOSLO:660428

Ideal exit: 21 Aug 2026 (T+270)

●

Michael Engsig

Executives10 Oct 2025(filed)Nykode Therapeutics ASA

NOK 100,1404Oslo ↗

55,944 shares@ NOK 1.7921.5% of flowShareXOSLOSLO:656985

Ideal exit: 7 Jul 2026 (T+270)

●

Michael Engsig

Executives29 Feb 2024(filed)Nykode Therapeutics ASA

NOK 100,2604Oslo ↗

6,000 shares@ NOK 16.7121.8% of flowShareXOSLOSLO:612321

Ideal exit: 25 Nov 2024 (T+270)

●

Michael Engsig

Executives30 Dec 2023Nykode Therapeutics ASA

2Oslo ↗

@ €0.7486OptionXOSLOSLO:604960

●

Michael Engsig

Executives31 Oct 2023(filed)Nykode Therapeutics ASA

NOK 168,4356Oslo ↗

9,850 shares@ NOK 17.1035.5% of flowShareXOSLOSLO:602645

Ideal exit: 27 Jul 2024 (T+270)

5 of 5 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

ME

Michael Engsig

NO·Oslo Børs

Nykode Therapeutics ASA

Cumul. flow

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Browse the full record of transactions filed by Michael Engsig. Insider active across 1 company, notably Nykode Therapeutics ASA. Aggregated, 5 reports have been published. Activity tracked since 31 October 2023. The latest transaction was disclosed on 24 November 2025 (Purchase). Regulator: Oslo Børs. The full history is openly available.

Declarations5 total

●

Michael Engsig

Executives24 Nov 2025(filed)Nykode Therapeutics ASA

NOK 100,1294Oslo ↗

46,356 shares@ NOK 2.1621.2% of flowShareXOSLOSLO:660428